fbpx
658 West Indiantown Rd., Suite 214, Jupiter, FL 33458
Cytonics Corporation Cytonics Corporation Cytonics Corporation
  • Search
  • FAQ
  • Management
  • News
    • BLOG
    • PRESS RELEASES
    • PEER REVIEWED PUBLICATIONS
  • Patents
  • Patients
    • Relief for Osteoarthritis
    • What Is A2M?
    • Insurance Coverage
    • Patient FAQ
    • Physician Locator
  • Physicians
    • Reimbursement
    • Research
    • How Cytonics can Help
    • FACT™
    • APIC™ System
    • Case Studies
    • Resources
  • Technology
    • The Problem
    • The Solution
    • A2M Therapy
    • A2M Technology
    • The Cytonics Advantage
    • Our Pipeline
    • Keys to Success
  • Videos
  • Invest Now
  • FAQ
  • Management
  • News
    • BLOG
    • PRESS RELEASES
    • PEER REVIEWED PUBLICATIONS
  • Patents
  • Patients
    • Relief for Osteoarthritis
    • What Is A2M?
    • Insurance Coverage
    • Patient FAQ
    • Physician Locator
  • Physicians
    • Reimbursement
    • Research
    • How Cytonics can Help
    • FACT™
    • APIC™ System
    • Case Studies
    • Resources
  • Technology
    • The Problem
    • The Solution
    • A2M Therapy
    • A2M Technology
    • The Cytonics Advantage
    • Our Pipeline
    • Keys to Success
  • Videos
  • Invest Now
  • Search

Finding the Replacement for HA Injections in the Knee

Finding the Replacement for HA Injections in the Knee

Orthopedics This Week -Volume 10, Issue 24

Post navigation

Previous
Next

Recent Posts

  • Cytonics Corporation and Astaria Global Announce an Exclusive Licensing Agreement
  • Alpha-2-Macroglobulin (A2M) Breakthrough Arthritis Treatment
  • Cytonics Receives Feedback from the FDA on Pre-Clinical and Phase 1 Trial Designs for Cyt-108
  • Cytonics Raises $794,000 to Fund Pre-Clinical Large Animal Studies for the Lead Recombinant Drug Candidate Cyt-108
  • The Impact of Proteins on Joints
  • Putting the Fight Back in Fighters with A2M
  • Cytonics Has Expressed and Purified an Enzymatically Active Recombinant Alpha-2-Macroglobulin Variant (Cyt-108)
  • Joint Pain in Young Adults
  • Non-Surgical Treatment for Musculoskeletal Pain
  • Cytonics Announces Issuance of PCT Patent for the APIC-PRP System and a Method of Producing Recombinant Alpha-2-Macroglobulin (A2M) Variants
  • Take Control of Chronic Back Pain with A2M Injections
  • Cytonics Announces Issuance of US Patent for the APIC-PRP System and a Method of Producing Recombinant Alpha-2-Macroglobulin (A2M) Variants
  • Cytonics Announces Issuance of UK Patent for the APIC-PRP System
  • Cytonics Announces Issuance of US Patent for a Method of Treatment of Chronic Wounds Using Alpha-2-Macroglobulin (A2M) from Whole Blood or a Recombinant Variant of A2M
  • Royce Gracie & A2M Therapy
  • Motorcycle accident launches Jupiter biotech enterprise
  • Cytonics Announces Issuance of UK Patent for an Alpha-2-Macroglobulin (A2M) Preparation from a Biological Sample
  • Cytonics’ APIC™ Procedure Highlighted by Local News Station
  • Finding the Replacement for HA Injections in the Knee
  • Cytonics Announces FDA Approval of an Investigational New Drug Application for the APIC Cell-Free System
  • Cytonics’ Breakthrough Research is Validated by Independent Study on A2M
  • Arthritis and Rheumatology – July 2014
  • Cytonics to Introduce the FACT™ Diagnostic for Joint and Spine Related Pain at the 2013 Workers Compensation Conference in Orlando, FL
  • The Spine Journal – April 2013
  • PM&R Journal – April 2013
  • DR. SCUDERI’S INCREDIBLE JOURNEY FROM CRASH VICTIM TO VISIONARY
  • Journal of Bone & Joint Surgery – December 2012
  • Cytonics Awarded Phase 2 NIH SBIR Grant
  • Cytonics Receives Notice of Allowance for Patent Related to FACT™ Diagnostic for Back and Joint Pain
  • Researchers create “truth serum” to explain knee pain
  • Orthopedic surgeon set bones, cleaned wounds, did amputations

Search the Site:

Archives

Contact Us

658 West Indiantown Rd.
Jupiter, FL 33458
Tel: (561) 747-9334

Fax: (561) 747-9633

Email: joey.bose@cytonics.com

Recent Posts:

  • Cytonics Corporation and Astaria Global Announce an Exclusive Licensing Agreement
  • Alpha-2-Macroglobulin (A2M) Breakthrough Arthritis Treatment

Videos:

More Videos

Home | FAQ | Contact |  Investors | Management | Media | Patents | Patients | Physicians |  Privacy / HIPPA |  Technology | Videos | Web Accessibility Policy
Marketing by Katapult Marketing
© 2023 Cytonics Corporation - All rights reserved
Join our NewsletterStay informed of all our news and happenings:

Please fill out all required fields.